Catalyst Wire Dossier Catalyst Wire Dossier

RmenB + OMV NZ meningitis vaccine

RmenB + OMV NZ · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RmenB + OMV NZ meningitis vaccine, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study to Assess the Immune Response And Safety Of Rmenb+Omv Nz In Primed Healthy Participants (10 To 20 Years Old) [Phase 3]

See pricing